OSR Health OSRHW
NASDAQ OSRHW
$0.05 +0.01 (+40.73%)
As of: Aug 24, 2026 · 3:58 PM EDT

OSR Health (OSRHW) Net Margin (2024 - 2026)

OSR Health (OSRHW) posted Net Margin of 605.6% for Q1 2026, up 52.12% sequentially from 1264.96% in Q4 2025, and up 89095.0% YoY from N/an in Q1 2025.

OSR Health (OSRHW) Net Margin (2024 - 2026) Analysis & Trends

OSR Health has reported Net Margin for 3 years, with the latest figure at 605.6% in Q1 2026.

  • Quarterly Net Margin rose 89095.0% year-over-year to 605.6% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 363.3% (up 17987.0% YoY) and the FY2025 annual result came in at 619.82%, down 32725.0% from the prior year.
  • Net Margin climbed to 605.6% in Q1 2026 per OSRHW's latest filing, from 1264.96% in the prior quarter.
  • Over five years, Net Margin peaked at 29.19% in Q2 2025 and troughed at 1496.55% in Q1 2025.
  • A 3-year average of 539.75% and a median of 368.63% in 2024 frame the typical range for Net Margin.
  • The sharpest annual moves came in 2025 and 2026: Net Margin sank 112792 bps in 2025, then soared 89095 bps in 2026.
  • Over 3 years, Net Margin stood at 146.36% in 2024, then slumped by 764 bps to 1264.96% in 2025, then soared by 52 bps to 605.6% in 2026.
  • According to Business Quant data, Net Margin over the past three periods registered 605.6%, 1264.96%, and 338.77% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Vertex Pharmaceuticals 138.97 Bn 131.12 Bn 2.84 Bn 32.99%
2 Regeneron Pharmaceuticals 85.15 Bn 77.15 Bn 3.93 Bn 30.23%
3 Argenx Se 62.84 Bn 57.65 Bn 1.37 Bn 31.16%
4 Moderna 55.74 Bn 50.60 Bn 52.00 Mn -539.31%
5 BeOne Medicines 41.53 Bn 36.43 Bn 1.53 Bn 13.90%
6 Alnylam Pharmaceuticals 31.60 Bn 28.29 Bn 992.69 Mn 12.74%
7 BioNTech SE 27.32 Bn 8.93 Bn 668.28 Mn -16.51%
8 Royalty Pharma 27.29 Bn 26.45 Bn - 12.09%
9 Insmed 26.99 Bn 25.83 Bn 358.27 Mn -3.12%
10 OSR Health 1.40 Mn 20.39 Mn 86,605.00 -268.92%

Historic Data

Download Data
DateValue
Mar 31, 2026 -605.60%
Dec 31, 2025 -1,264.96%
Sep 30, 2025 -338.77%
Jun 30, 2025 29.19%
Mar 31, 2025 -1,496.55%
Dec 31, 2024 -146.36%
Sep 30, 2024 -407.84%
Jun 30, 2024 -258.27%
Mar 31, 2024 -368.63%